Influenza B/Victoria Lineage Viruses Hemagglutinin (HA) Specific ELISA Kit

ユーザーレビュー
製品番号/仕様
価格
数量
RAS-A206-96tests
$805.00
ETA of in-stock products:2 business days
総アイテム数 製品金額$ 0

製品詳細

  • Materials Provided

    ID
    Components
    Size
    RAS206-C01
    Pre-coated Anti-HA (Influenza B/Victoria Lineage) Antibody Microplate
    1 plate
    RAS206-C02
    HA (Influenza B/Victoria Lineage) Standard
    20 μg
    RAS206-C03
    HRP-Anti-HA (Influenza B/Victoria Lineage) Antibody
    20 μg
    RAS206-C04
    10×Washing Buffer
    50 mL
    RAS206-C05
    2×Dilution Buffer
    50 mL
    RAS206-C06
    Substrate Solution
    12 mL
    RAS206-C07
    Stop Solution
    7 mL

  • Product Overview

    Influenza B/Victoria Lineage Viruses Hemagglutinin (HA) Specific ELISA Kit is based on the sandwich-ELISA method and is used to specifically detect and quantitatively determine Influenza B/Victoria lineage virus HA protein in vaccine samples. The kit is designed to provide a reliable solution for the manufacturing and quality control of HA vaccine development.

  • Reconstitution

    Please see Certificate of Analysis for details of reconstitution instruction and specific concentration.

  • Storage

    1. Unopened kit should be stored at 2℃-8℃ upon receiving.

    2. Find the expiration date on the outside packaging and do not use reagents past their expiration date.

    3. The opened kit should be stored per components table. The shelf life is 30 days from the date of opening.

  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

お客様はこちらも閲覧

データ表示

  • Typical Data 

    Please refer to DS document for the assay protocol.

     Hemagglutinin/HA (Influenza Virus) TYPICAL DATA

    For each experiment, a standard curve needs to be set for each micro-plate, and the specific OD value may vary depending on different laboratories, testers, or equipments. The following example data is for reference only.

  •  Hemagglutinin/HA (Influenza Virus) TYPICAL DATA

    The kit has been tested to specifically identify Influenza B [Austria/1359417/2021 (B/Victoria lineage)] HA, and do not identify Influenza B [Phuket/3073/2013 (B/Yamagata lineage)] HA, Influenza A [Victoria/4897/2022 (H1N1)] HA, Influenza A [Wisconsin/67/2022(H1N1)] HA, Influenza A (A/Thailand/8/2022) & (A/Massachusetts/18/2022) HA (H3N2), Influenza A [A/Darwin/6/2021 (H3N2)] HA , Influenza A [A/Darwin/9/2021 (H3N2)] HA, Influenza A [A/District of Columbia/27/2023 (H3N2)] HA and Influenza A [A/Croatia/10136RV/2023 (H3N2)] HA.

ユーザーレビュー
コメントを投稿

最新の進展

 
お問い合わせ
医薬品候補ライセンス
他の関連情報
  • 製品情報
  • 製品詳細
  • お客様はこちらも閲覧
  • データ表示
  • ユーザーレビュー
お問い合わせ

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8